STUDY PSILOCYBIN-BASED MEDICATION TREATMENT

This House Memorial (HM 58) requests New Mexico's Department of Health to study psilocybin-based medication treatments. The study would examine training requirements for medical professionals, safety testing protocols, regulatory barriers, equity access strategies, and potential licensing frameworks for these treatments. It does not authorize or regulate psilocybin use but aims to inform future policy by gathering evidence on safe, effective, and equitable implementation for New Mexico residents.